Susquehanna International Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Sell |
211,600
-3,688
| -2% | -$12.5K | ﹤0.01% | 3797 |
|
|
2025
Q1 | $863K | Buy |
215,288
+158,393
| +278% | +$635K | ﹤0.01% | 3570 |
|
|
2024
Q4 | $369K | Buy |
56,895
+39,891
| +235% | +$259K | ﹤0.01% | 4479 |
|
|
2024
Q3 | $94.2K | Sell |
17,004
-75,780
| -82% | -$420K | ﹤0.01% | 5139 |
|
|
2024
Q2 | $518K | Buy |
92,784
+69,284
| +295% | +$387K | ﹤0.01% | 3470 |
|
|
2024
Q1 | $158K | Sell |
23,500
-52,608
| -69% | -$353K | ﹤0.01% | 4808 |
|
|
2023
Q4 | $694K | Buy |
+76,108
| New | +$694K | ﹤0.01% | 3377 |
|
|
2023
Q3 | – | Sell |
-67,320
| Closed | -$575K | – | 5688 |
|
|
2023
Q2 | $575K | Sell |
67,320
-239,700
| -78% | -$2.05M | ﹤0.01% | 3432 |
|
|
2023
Q1 | $2.82M | Buy |
+307,020
| New | +$2.82M | ﹤0.01% | 1592 |
|
|
2022
Q4 | – | Sell |
-40,559
| Closed | -$597K | – | 5979 |
|
|
2022
Q3 | $597K | Buy |
+40,559
| New | +$597K | ﹤0.01% | 3285 |
|
|
2022
Q2 | – | Sell |
-23,590
| Closed | -$254K | – | 5945 |
|
|
2022
Q1 | $254K | Buy |
+23,590
| New | +$254K | ﹤0.01% | 4551 |
|